ClinicalTrials.Veeva

Menu

"Impact of Pelvic Floor Prehabilitation Using Biofeedback on the Severity of the Low Anterior Resection Syndrome in Patients Undergoing a Total Mesorectal Excision for Rectal Cancer" (CONTICARE)

N

Nantes University Hospital (NUH)

Status

Unknown

Conditions

Rectal Cancer

Treatments

Procedure: Pelvic floor prehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT03876561
RC16_0459

Details and patient eligibility

About

There is currently no specific treatment and only few measures to prevent the low anterior resection syndrome (LARS). The LARS often results in a severe alteration of quality of life. This study is designed to assess pelvic floor prehabilitation using biofeedback in the prevention of LARS following total mesorectal excision for cancer. The pelvic floor rehabilitation with biofeedback has already been tested postoperatively in patients suffering from LARS with heterogeneous results. However, this rehabilitation has never been evaluated in the prevention of LARS.

The prehabilitation is an innovative concept currently evaluated in the prevention of functional complications following orthopedic surgery and also prostate surgery. In high-risk abdominal surgery, cardiopulmonary prehabilitation offers satisfying results in terms of morbidity and mortality rates. This study will be the first to assess pelvic floor prehabilitation in the prevention of LARS.

Enrollment

174 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 80 years old
  • Total mesorectal excision with colorectal or coloanal anastomosis protected by an ileostomy or a colostomy for rectal cancer
  • Absence of anastomotic leakage or stenosis
  • Informed consent to participate in the study
  • Social security insurance affiliation

Exclusion criteria

  • History of anal incontinence and/or fecal urgency and/or chronic diarrhea requiring a specific treatment before rectal cancer management
  • Absence of ileostomy or colostomy
  • Anastomotic leakage
  • Sensorial or cognitive disorders impeding pelvic floor rehabilitation exercise
  • Pregnant women
  • Minors
  • Adults under guardianship

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

174 participants in 2 patient groups

Prehabilitation
Experimental group
Description:
The systematic pelvic floor prehabilitation will start 4 weeks before stoma closure and will include 1 sessions per week before stoma closure and 1 sessions per week during 6 weeks following stoma closure. Complementary sessions are allowed if necessary.
Treatment:
Procedure: Pelvic floor prehabilitation
No intervention
No Intervention group
Description:
No pelvic floor prehabilitation will be proposed before stoma closure. The pelvic floor prehabilitation will be proposed to patients suffering from LARS

Trial contacts and locations

6

Loading...

Central trial contact

Guillaume MEURETTE; Emilie DUCHALAIS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems